Stay updated on BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Sign up to get notified when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.

Latest updates to the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.5.0 added. The page no longer includes 'Multiple myeloma' or 'MedlinePlus Genetics' as related topics in the related topics section.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedMetadata and taxonomy updates were applied to the study page, including new date entries and related topic references (Multiple myeloma and MedlinePlus Genetics). The revision tag was updated from v3.4.2 to v3.4.3, and older revision entries were removed.SummaryDifference0.6%

- Check29 days agoChange DetectedRemoved references to Multiple Myeloma and MedlinePlus Genetics from the page.SummaryDifference0.2%

- Check43 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No study content or user-facing features were altered.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded related topics 'Multiple Myeloma' and 'MedlinePlus Genetics'. Updated the footer to Revision: v3.4.1.SummaryDifference0.2%

- Check51 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics; updated revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.